1. Home
  2. IQV vs KEYS Comparison

IQV vs KEYS Comparison

Compare IQV & KEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • KEYS
  • Stock Information
  • Founded
  • IQV 1982
  • KEYS 1939
  • Country
  • IQV United States
  • KEYS United States
  • Employees
  • IQV N/A
  • KEYS N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • KEYS Industrial Machinery/Components
  • Sector
  • IQV Health Care
  • KEYS Industrials
  • Exchange
  • IQV Nasdaq
  • KEYS Nasdaq
  • Market Cap
  • IQV 31.6B
  • KEYS 27.7B
  • IPO Year
  • IQV 2013
  • KEYS N/A
  • Fundamental
  • Price
  • IQV $156.39
  • KEYS $127.04
  • Analyst Decision
  • IQV Strong Buy
  • KEYS Buy
  • Analyst Count
  • IQV 18
  • KEYS 9
  • Target Price
  • IQV $248.72
  • KEYS $184.44
  • AVG Volume (30 Days)
  • IQV 1.6M
  • KEYS 864.6K
  • Earning Date
  • IQV 05-01-2025
  • KEYS 05-19-2025
  • Dividend Yield
  • IQV N/A
  • KEYS N/A
  • EPS Growth
  • IQV 2.74
  • KEYS N/A
  • EPS
  • IQV 7.49
  • KEYS 3.50
  • Revenue
  • IQV $15,405,000,000.00
  • KEYS $5,018,000,000.00
  • Revenue This Year
  • IQV $4.25
  • KEYS $7.55
  • Revenue Next Year
  • IQV $6.17
  • KEYS $6.65
  • P/E Ratio
  • IQV $22.38
  • KEYS $43.36
  • Revenue Growth
  • IQV 2.81
  • KEYS N/A
  • 52 Week Low
  • IQV $166.16
  • KEYS $119.72
  • 52 Week High
  • IQV $252.88
  • KEYS $186.20
  • Technical
  • Relative Strength Index (RSI)
  • IQV 24.11
  • KEYS 22.17
  • Support Level
  • IQV $169.37
  • KEYS $143.98
  • Resistance Level
  • IQV $188.39
  • KEYS $152.58
  • Average True Range (ATR)
  • IQV 5.33
  • KEYS 4.34
  • MACD
  • IQV -1.74
  • KEYS -1.62
  • Stochastic Oscillator
  • IQV 2.23
  • KEYS 2.99

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About KEYS Keysight Technologies Inc.

Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.

Share on Social Networks: